Top Markets
Coin of the day
Boston Scientific Corporation Boston Scientific Corporation

Boston Scientific Corporation

BSX
Classificação em ações #210
Boston Scientific Corporation develops, manufactures, and markets medical... Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Preço da ação
$62.83
Valor de mercado
$93.23B
Variação (1 dia)
-9.17%
Variação (1 ano)
-31.36%
País
US
Negociar Boston Scientific Corporation (BSX)

Categoria

Lucros da Boston Scientific Corporation (BSX)
Lucros em Dec 2025 TTM: $3.39B
De acordo com os últimos relatórios financeiros da Boston Scientific Corporation, os ganhos atuais da empresa são de $3.39B. Em 2024, a empresa teve ganhos de $2.28B, um aumento em relação a aos ganhos de 2023, que foram de $1.99B. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Boston Scientific Corporation de 2000 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $3.39B 0.00%
2025 $3.39B 48.33%
2024 $2.28B 14.96%
2023 $1.99B 73.97%
2022 $1.14B 6.04%
2021 $1.08B -1,462.03%
2020 $-79.00M -111.50%
2019 $687.00M -51.69%
2018 $1.42B 52.41%
2017 $933.00M 427.12%
2016 $177.00M -127.23%
2015 $-650.00M 27.70%
2014 $-509.00M 128.25%
2013 $-223.00M -94.57%
2012 $-4.11B -739.72%
2011 $642.00M -160.40%
2010 $-1.06B -18.73%
2009 $-1.31B -35.60%
2008 $-2.03B 256.94%
2007 $-569.00M -83.90%
2006 $-3.54B -496.75%
2005 $891.00M -40.36%
2004 $1.49B 132.35%
2003 $643.00M 17.12%
2002 $549.00M 1,147.73%
2001 $44.00M -91.65%
2000 $527.00M 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$8.47B 150.10%
US
$4.51B 33.35%
US
$5.56B 64.38%
IE
$5.56B 64.34%
IE
$3.13B -7.48%
DE